pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 28·1 min read
save

For wearables, it’s a GLP-1 world

We have two pieces of wearables-related news for you today, and (maybe unsurprisingly) GLP-1s came up in our conversations with both companies. First, Signos raised $20 million for its approach ...

May 28, 2026·read at Endpoints ↗

May 28, 2026 11:58 AM EDT Health Tech For wear­ables, it’s a GLP-1 world Shelby Livingston Health tech correspondent Lydia Ramsey Pflanzer Deputy Editor We have two pieces of wear­ables-re­lat­ed news for you to­day, and (maybe un­sur­pris­ing­ly) GLP-1s came up in our con­ver­sa­tions with both com­pa­nies. First, Sig­nos Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
82 words · retrieved Jun 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
GLP-1 receptor2

related stories

  • May 19STAT+: Dexcom CEO hints at future uses for CGMSTAT
  • May 18Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drugBioPharma Dive
  • May 18STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much moreSTAT
  • May 15FDA hold puts Aardvark Prader-Willi drug in limboBioPharma Dive
  • May 15India’s pharma industry is going global. But can it catch up to China?BioPharma Dive